Cargando…
Ferumoxytol magnetic resonance angiography: a dose-finding study in patients with chronic kidney disease
OBJECTIVES: Ferumoxytol is an alternative to gadolinium-based compounds as a vascular contrast agent for magnetic resonance angiography (MRA), particularly for patients with chronic kidney disease (CKD). However, dose-related efficacy data are lacking. We aimed to determine the optimal (minimum effe...
Autores principales: | Stoumpos, Sokratis, Hennessy, Martin, Vesey, Alex T., Radjenovic, Aleksandra, Kasthuri, Ram, Kingsmore, David B., Mark, Patrick B., Roditi, Giles |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Springer Berlin Heidelberg
2019
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6554242/ https://www.ncbi.nlm.nih.gov/pubmed/30919067 http://dx.doi.org/10.1007/s00330-019-06137-4 |
Ejemplares similares
-
Ferumoxytol-enhanced magnetic resonance angiography for the assessment of potential kidney transplant recipients
por: Stoumpos, Sokratis, et al.
Publicado: (2017) -
Research cardiac magnetic resonance imaging in end stage renal disease - incidence, significance and implications of unexpected incidental findings
por: Rutherford, Elaine, et al.
Publicado: (2016) -
Magnetic resonance imaging incidents are severely underreported: a finding in a multicentre interview survey
por: Kihlberg, Johan, et al.
Publicado: (2021) -
Reduced magnetic resonance angiography signal intensity in the middle cerebral artery ipsilateral to severe carotid stenosis may be a practical index of high oxygen extraction fraction
por: Mori, Takahisa, et al.
Publicado: (2021) -
Concomitant chronic venous insufficiency in patients with peripheral artery disease: insights from MR angiography
por: Ammermann, Felix, et al.
Publicado: (2020)